Cancer Stock Breaks Out To Highs; Key FDA Action On Watch

Even as the recent euphoria surrounding a cancer vaccine breakthrough from Moderna (MRNA) takes a pause, investors are increasing their bets on cancer treatment name Exelixis (EXEL). The stock's breakout on Wednesday makes it the IBD 50 Stocks To Watch pick. Exelixis shares hit an all-time high Wednesday. The stock's relative strength line is rising as it clears a third-stage…